NEW YORK, March 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023 and December 26, 2025, inclusive (the “Class Period”), of the important April 6, 2026 lead plaintiff deadline. SO WHAT: If you purchased Mereo ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities between February 26, 2025, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 2, 2026 [3]. - The lawsuit alleges that defendants made false or misleading statements regarding agilon's financial guidance and the impact of strategic actions taken to reduce risk, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a leading company in the field of immuno-dermatology, is set to participate in the TD Cowen 46th Annual Health Care Conference from March 2-4, 2026, in Boston. The company's management will engage in a fireside chat on March 2 at 1:50 p.m. ET, which will be available via a webcast on their website for 180 days.Arcutis is renowned for its commitment to developing innovative treatments for patients with immune-mediated dermatological conditions. The company boasts ...

leukemia. J Clin Oncol. 2017;35(13):1437-1443. doi:10.1200/JCO.2016.70.22826. Sharman JP,et al.2024 ASH Oral presentation #8867. Mato AR, Shah NN, Jurczak W, et al. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet. 2021;397(10277):892-901. doi:10.1016/S0140- 6736(21)00224-58. Jaypirca. Prescribing Information. Lilly USA, LLC.SOURCE Innovent Biologics## 21% [more press release views with Request a Demo]## Also from this source### Innovent Dosed First Participant ...

US stock futures tumbled on Monday while oil prices surged after military strikes by the US and Israel on Iran were followed by counterattacks, sending shockwaves through global markets. Dow Jones Industrial Average futures (YM=F) slumped 1.2%, or over 500 points. Contracts on the S&P 500 (ES=F) sank 1.1%, while those on the tech-heavy Nasdaq 100 (NQ=F) dived 1.4% as the escalating Middle East conflict spurred a retreat from risk assets. The impact on oil prices, and in turn on inflation, is front of mi ...

Group 1 - Gold and silver prices increased due to military strikes by the U.S. and Israel against Iran, which heightened safe-haven demand [1] - eToro indicated that gold serves as a clear indicator of investor fear [1]

US stock futures plunged on Monday while oil prices surged, as military strikes by the US and Israel on Iran jolted global markets. Dow Jones Industrial Average futures (YM=F) tumbled 1.6%, or over 800 points. Contracts on the S&P 500 (ES=F) sank 1.7%, while those on the tech-heavy Nasdaq 100 (NQ=F) dived 2% as the escalating Middle East conflict spurred a retreat from risk assets. The strikes on Iran began late Saturday after Tehran rejected US demands to scale back its nuclear program. Its Supreme Lea ...

US stock futures tumbled on Monday while oil prices surged after military strikes by the US and Israel on Iran were followed by counterattacks, sending shockwaves through global markets. Dow Jones Industrial Average futures (YM=F) slumped 1.2%, or over 500 points. Contracts on the S&P 500 (ES=F) sank 1.1%, while those on the tech-heavy Nasdaq 100 (NQ=F) dived 1.4% as the escalating Middle East conflict spurred a retreat from risk assets. The impact on oil prices, and in turn on inflation, is front of mi ...

US stocks tumbled on Monday while oil prices surged after military strikes by the US and Israel on Iran were followed by counterattacks, sending shockwaves through global markets. The Dow Jones Industrial Average (^DJI) slumped 1.1%, or just over 500 points. Meanwhile, the S&P 500 (^GSPC) sank roughly 1%, while the tech-heavy Nasdaq Composite (^IXIC) dived roughly 1.1% as the escalating Middle East conflict spurred a retreat from risk assets. The impact on oil prices, and in turn on inflation, is front ...

Geopolitical Impact - US and Israel conducted military strikes on Iran, leading to a significant drop in US stock futures, with Dow Jones futures down about 1%, S&P 500 down 0.5%, and Nasdaq 100 down around 0.3% [1] - Iranian leaders have vowed a strong response, raising concerns about a potential broader regional conflict [1] Oil Market Reaction - Brent crude futures surged approximately 13% in early trading, reaching $82 per barrel due to supply fears, as Iran is OPEC's fourth-largest producer [2] - The geopolitical situation has heightened concerns regarding political leadership and stability in Iran following the death of Khamenei [2] Equity Market Environment - The S&P 500 closed lower at the end of February, reflecting ongoing volatility in artificial intelligence and software sectors, with investors questioning the impact of rapid AI adoption on traditional software business models [3] Economic Calendar - The upcoming February jobs report is anticipated, with Wall Street expecting the addition of 60,000 jobs, a decrease from January's 130,000 gain [4] - Corporate earnings reports are scheduled, with Broadcom reporting on Wednesday and Marvell Technology on Thursday, alongside retail earnings from Target and Costco [4]